Entrada Therapeutics, Inc. revenue breakdown overview

Entrada Therapeutics, Inc. revenue for the last year amounted to 210.78 M USD, the most of which — 210.78 M USD — came from its highest performing source at the moment, Endosomal Escape Vehicle Therapeutics, the year earlier bringing 129.01 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Entrada Therapeutics, Inc. 210.78 M USD, and the year before that — 129.01 M USD.